WO2004043351A3 - Soluble oral patch with collagen and interlaced active ingredients - Google Patents
Soluble oral patch with collagen and interlaced active ingredients Download PDFInfo
- Publication number
- WO2004043351A3 WO2004043351A3 PCT/US2003/034549 US0334549W WO2004043351A3 WO 2004043351 A3 WO2004043351 A3 WO 2004043351A3 US 0334549 W US0334549 W US 0334549W WO 2004043351 A3 WO2004043351 A3 WO 2004043351A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oral patch
- temperatures
- hydrophilic polymer
- network
- collagen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002505126A CA2505126A1 (en) | 2002-11-05 | 2003-10-29 | Soluble oral patch with collagen and interlaced active ingredients |
AU2003287313A AU2003287313A1 (en) | 2002-11-05 | 2003-10-29 | Soluble oral patch with collagen and interlaced active ingredients |
EP03781546A EP1567102A2 (en) | 2002-11-05 | 2003-10-29 | Soluble oral patch with collagen and interlaced active ingredients |
JP2004551629A JP2006505614A (en) | 2002-11-05 | 2003-10-29 | Dissolvable oral patch containing collagen and reticulated active ingredients |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23628902A | 2002-09-04 | 2002-09-04 | |
US10/287,843 | 2002-11-05 | ||
US10/287,843 US20030124178A1 (en) | 2001-12-28 | 2002-11-05 | Soft, adherent, soluble oral patch |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004043351A2 WO2004043351A2 (en) | 2004-05-27 |
WO2004043351A3 true WO2004043351A3 (en) | 2004-08-26 |
Family
ID=32314338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/034549 WO2004043351A2 (en) | 2002-09-04 | 2003-10-29 | Soluble oral patch with collagen and interlaced active ingredients |
Country Status (2)
Country | Link |
---|---|
US (1) | US20030124178A1 (en) |
WO (1) | WO2004043351A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070098648A1 (en) * | 2002-11-05 | 2007-05-03 | Haley Jeffrey T | Treating mouth sores caused by dental braces with blobs of hydrophilic gums |
US20050136112A1 (en) * | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
US8945606B2 (en) * | 2006-04-13 | 2015-02-03 | OralHealth Corp. | Oral adhering disc with dimple on adhering side |
US20070243238A1 (en) | 2006-04-13 | 2007-10-18 | Haley Jeffrey T | Treating mouth sores with patches adhered to teeth |
JP2009538913A (en) * | 2006-05-30 | 2009-11-12 | ハーレイ,ジェフリー,ティー. | Cobalamin formulation and mucositis treatment or prevention |
ATE464916T1 (en) * | 2006-11-06 | 2010-05-15 | Lohmann & Rauscher Gmbh & Co Kg | PRODUCT FOR THE TREATMENT OF INFLAMMATION, PRESSURE SORES AND/OR APHATOES IN THE ORAL AREA AND USE OF SUCH A PRODUCT |
US9549842B2 (en) | 2011-02-04 | 2017-01-24 | Joseph E. Kovarik | Buccal bioadhesive strip and method of treating snoring and sleep apnea |
US8701671B2 (en) | 2011-02-04 | 2014-04-22 | Joseph E. Kovarik | Non-surgical method and system for reducing snoring |
US10548761B2 (en) | 2011-02-04 | 2020-02-04 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
US11357722B2 (en) | 2011-02-04 | 2022-06-14 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
ES2659763T3 (en) | 2011-02-14 | 2018-03-19 | The Regents Of The University Of Michigan | Compositions and procedures for the treatment of obesity and related disorders |
US9796769B2 (en) * | 2012-09-28 | 2017-10-24 | Ension Inc. | Methods of making bioactive collagen medical scaffolds such as for wound care dressings, hernia repair prosthetics, and surgical incision closure members |
US10744039B2 (en) | 2012-09-28 | 2020-08-18 | Ension Inc. | Methods of making bioactive collagen wound care dressings |
CA2894160C (en) * | 2012-12-07 | 2024-01-02 | Anthrogenesis Corporation | Treating oral lesions using placental extracellular matrix |
ES2727898T3 (en) * | 2013-05-02 | 2019-10-21 | Univ Michigan Regents | Deuterated Amlexanox with enhanced metabolic stability |
US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
JP7292034B2 (en) | 2015-09-09 | 2023-06-16 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Tooth adhesive patch that can be removed by tooth brushing |
CN108135784B (en) | 2015-10-06 | 2022-05-27 | 株式会社Lg生活健康 | Removable dental patch by brushing |
EP3407974A4 (en) | 2016-01-29 | 2019-08-28 | The Regents Of The University Of Michigan | Amlexanox analogs |
EP3492073B1 (en) | 2016-07-27 | 2022-04-27 | Ritapharma, Co., Ltd. | Oral mucosa application material and method for producing same |
US11612564B2 (en) | 2018-04-21 | 2023-03-28 | Quest Products, Llc | Bilayer adhering lozenge effective to mask undesirable flavor |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174873B1 (en) * | 1998-11-04 | 2001-01-16 | Supergen, Inc. | Oral administration of adenosine analogs |
US6319510B1 (en) * | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4795436A (en) * | 1983-11-14 | 1989-01-03 | Bio-Mimetics, Inc. | Bioadhesive composition and method of treatment therewith |
EP0200508B1 (en) * | 1985-04-27 | 1991-10-02 | Nitto Denko Corporation | Adhesive oral bandages and oral pharmaceutical preparations |
JPH0729915B2 (en) * | 1986-02-01 | 1995-04-05 | 帝國製薬株式会社 | Sheet-shaped oral patch |
US5077051A (en) * | 1990-04-10 | 1991-12-31 | Warner-Lambert Company | Sustained release of active agents from bioadhesive microcapsules |
WO1993013756A1 (en) * | 1992-01-10 | 1993-07-22 | Obschestvo S Ogranichennoy Otvetstvennostyu Meditsinsky Nauchno-Proizvodstvennoy Komplex 'biotiki' | Granulated pharmaceutical composition and method of obtaining it |
WO1993023011A1 (en) * | 1992-05-18 | 1993-11-25 | Minnesota Mining And Manufacturing Company | Transmucosal drug delivery device |
US5330761A (en) * | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
US5409703A (en) * | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
US6426085B1 (en) * | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US5713852A (en) * | 1995-06-07 | 1998-02-03 | Alza Corporation | Oral dosage and method for treating painful conditions of the oral cavity |
US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
US6197331B1 (en) * | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
US6139861A (en) * | 1999-01-14 | 2000-10-31 | Friedman; Mark | Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
US6248718B1 (en) * | 1999-08-18 | 2001-06-19 | Atlantic Biomed Corporation | Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity |
US6555125B2 (en) * | 1999-11-30 | 2003-04-29 | Phillip Campbell | Lesion and ulcer medication |
JP4459414B2 (en) * | 2000-08-24 | 2010-04-28 | 日東電工株式会社 | Oral patch preparation |
ATE525061T1 (en) * | 2001-02-28 | 2011-10-15 | Axiomedic Ltd | SOLID SELF-ADHESIVE COMPOSITIONS FOR THE TOPICAL TREATMENT OF DISORDERS OF THE ORAL MUCOSA |
US6585997B2 (en) * | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
-
2002
- 2002-11-05 US US10/287,843 patent/US20030124178A1/en not_active Abandoned
-
2003
- 2003-10-29 WO PCT/US2003/034549 patent/WO2004043351A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174873B1 (en) * | 1998-11-04 | 2001-01-16 | Supergen, Inc. | Oral administration of adenosine analogs |
US6319510B1 (en) * | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
Also Published As
Publication number | Publication date |
---|---|
WO2004043351A2 (en) | 2004-05-27 |
US20030124178A1 (en) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004043351A3 (en) | Soluble oral patch with collagen and interlaced active ingredients | |
RU2460519C2 (en) | Biodegradable plaster | |
RU2297213C2 (en) | Rapid degradation dosage form releasing active components into oral cavity or body cavities | |
EP1534253B1 (en) | Process for making orally consumable dosage forms | |
CA1248450A (en) | Soft patch | |
WO2010143196A1 (en) | Novel synergistic transparent / translucent hydrogel composition; method of preparing it and a sheet / film made thereform | |
US20070196441A1 (en) | Process for Making Orally Consumable Dosage Forms | |
AU2003233304B2 (en) | Film-shaped, dissolvable preparations for active substance release and method for the production thereof | |
CN105395469A (en) | Freeze-dried Composition Of Active Substances | |
JP6779308B2 (en) | Gel-filled beauty mask | |
CN105229401A (en) | The method of wet film drying is made by controlling loss on drying | |
RU2006147244A (en) | METHOD FOR FORMING QUICKLY DISPERSABLE MEDICINAL FORMS CONTAINING AT LEAST ONE FISH GELATIN, WHICH ARE SELECTED ON THE BASIS OF MOLECULAR MASS | |
El-Feky et al. | Mucosal co-delivery of ketorolac and lidocaine using polymeric wafers for dental application | |
US20070243238A1 (en) | Treating mouth sores with patches adhered to teeth | |
ATE326264T1 (en) | PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS CONTAINING LACTIC ACID POLYMER AND THEIR PRODUCTION | |
CA3110849A1 (en) | Pharmaceutical formulation and system and method for delivery | |
CN108159024A (en) | A kind of sustained release pad pasting for treating canker sore and preparation method thereof | |
KR20210024080A (en) | Oral composition and mucoadhesive thin film formed therefrom | |
US20090098188A1 (en) | Method for delivery of medication using a dissolvable device | |
CN110302144B (en) | Slow-release double-layer oral ulcer membrane and preparation method thereof | |
JP2003070898A (en) | Plaster and production method thereof | |
CN101346135A (en) | PH modulated films for delivery of actives | |
JP2007506670A (en) | Transmucosal form of administration with reduced mucosal irritation | |
ES2221840T3 (en) | COMPOSITION OR EXPANDED MICROPOROUS STRUCTURE ISOTROP OF QUICK DISSOLUTION FOR PHARMACEUTICAL, VETERINARY, DIETETIC, FOOD OR COSMETIC USE AND ITS OBTAINING PROCEDURE. | |
EA200700877A1 (en) | PHARMACEUTICAL COMPOSITION DISPOSABLE IN THE MOUTH AND THE METHOD OF ITS PREPARATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2505126 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004551629 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003287313 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003781546 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038A83213 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003781546 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003781546 Country of ref document: EP |